BIOMAT Database Logo BIOMAT Database Logo

[Brain-derived neurotrophic factor as a biomarker of childhood metabolic syndrome]. 2020

Guillermo Gómez Delgado, and Paola Trinidad Villalobos Gutiérrez, and José Luis Muñoz Carillo, and Oscar Gutiérrez Coronado
Centro Universitario de los Lagos (CULAGOS), Universidad de Guadalajara, Lagos de Moreno, Jalisco, México.

UI MeSH Term Description Entries
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences
D019208 Brain-Derived Neurotrophic Factor A member of the nerve growth factor family of trophic factors. In the brain BDNF has a trophic action on retinal, cholinergic, and dopaminergic neurons, and in the peripheral nervous system it acts on both motor and sensory neurons. (From Kendrew, The Encyclopedia of Molecular Biology, 1994) BDNF,Brain Derived Neurotrophic Factor,Factor, Brain-Derived Neurotrophic,Neurotrophic Factor, Brain-Derived
D024821 Metabolic Syndrome A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state. Cardiometabolic Syndrome,Insulin Resistance Syndrome X,Metabolic Syndrome X,Reaven Syndrome X,Dysmetabolic Syndrome X,Metabolic Cardiovascular Syndrome,Metabolic X Syndrome,Syndrome X, Insulin Resistance,Syndrome X, Metabolic,Cardiometabolic Syndromes,Cardiovascular Syndrome, Metabolic,Cardiovascular Syndromes, Metabolic,Metabolic Syndromes,Syndrome X, Dysmetabolic,Syndrome X, Reaven,Syndrome, Cardiometabolic,Syndrome, Metabolic,Syndrome, Metabolic Cardiovascular,Syndrome, Metabolic X,Syndromes, Cardiometabolic,Syndromes, Metabolic,X Syndrome, Metabolic

Related Publications

Guillermo Gómez Delgado, and Paola Trinidad Villalobos Gutiérrez, and José Luis Muñoz Carillo, and Oscar Gutiérrez Coronado
Brain-derived neurotrophic factor as biomarker.
February 2020, Anatolian journal of cardiology,
Guillermo Gómez Delgado, and Paola Trinidad Villalobos Gutiérrez, and José Luis Muñoz Carillo, and Oscar Gutiérrez Coronado
Urinary brain-derived neurotrophic factor as a biomarker of executive functioning.
January 2014, Neuropsychobiology,
Guillermo Gómez Delgado, and Paola Trinidad Villalobos Gutiérrez, and José Luis Muñoz Carillo, and Oscar Gutiérrez Coronado
Brain-derived neurotrophic factor as a biomarker in primary open-angle glaucoma.
January 2011, Optometry and vision science : official publication of the American Academy of Optometry,
Guillermo Gómez Delgado, and Paola Trinidad Villalobos Gutiérrez, and José Luis Muñoz Carillo, and Oscar Gutiérrez Coronado
Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker for affective disorders?
February 2010, The international journal of neuropsychopharmacology,
Guillermo Gómez Delgado, and Paola Trinidad Villalobos Gutiérrez, and José Luis Muñoz Carillo, and Oscar Gutiérrez Coronado
A Review of Brain-derived Neurotrophic Factor as a Candidate Biomarker in Schizophrenia.
August 2012, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology,
Guillermo Gómez Delgado, and Paola Trinidad Villalobos Gutiérrez, and José Luis Muñoz Carillo, and Oscar Gutiérrez Coronado
Brain Derived Neurotrophic Factor as a Non-invasive Biomarker for Detection of Endometriosis.
January 2022, Journal of reproduction & infertility,
Guillermo Gómez Delgado, and Paola Trinidad Villalobos Gutiérrez, and José Luis Muñoz Carillo, and Oscar Gutiérrez Coronado
Brain-derived neurotrophic factor: a biomarker for obsessive-compulsive disorder?
January 2015, Frontiers in neuroscience,
Guillermo Gómez Delgado, and Paola Trinidad Villalobos Gutiérrez, and José Luis Muñoz Carillo, and Oscar Gutiérrez Coronado
Serum concentrations of brain-derived neurotrophic factor as a potential biomarker of swine welfare.
May 2023, The Canadian veterinary journal = La revue veterinaire canadienne,
Guillermo Gómez Delgado, and Paola Trinidad Villalobos Gutiérrez, and José Luis Muñoz Carillo, and Oscar Gutiérrez Coronado
Brain-derived neurotrophic factor as a biomarker for obsessive-compulsive disorder: A meta-analysis.
July 2022, Journal of psychiatric research,
Guillermo Gómez Delgado, and Paola Trinidad Villalobos Gutiérrez, and José Luis Muñoz Carillo, and Oscar Gutiérrez Coronado
Brain-derived neurotrophic factor and the metabolic syndrome: more than just a hypothesis.
January 2006, Medical hypotheses,
Copied contents to your clipboard!